KUSLIMA SHOGEN Insider Trading $ACEL.OB TAMIR BIOTECHNOLOGY, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KUSLIMA SHOGEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KUSLIMA SHOGEN. KUSLIMA SHOGEN is CEO in Tamir Biotechnology, Inc. ($ACEL.OB) and CEO & Acting CFO in Tamir Biotechnology, Inc. ($ACEL.OB).
KUSLIMA SHOGEN in TAMIR BIOTECHNOLOGY, INC.
Trading Symbol: ACEL.OBIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KUSLIMA SHOGEN: CEO & Acting CFO
Holdings: 543,445 shares
Latest Transaction: Oct 18 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KUSLIMA SHOGEN in TAMIR BIOTECHNOLOGY, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 18 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | M | 0.54 | 23,000 | 12,420 | 46,000 | |
Oct 18 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | M | 0.54 | 23,000 | 12,420 | 543,445 | 520.4 K to 543.4 K (+4.42 %) |
Oct 10 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | A | 1.29 | 120,000 | 154,800 | 120,000 | |
Oct 04 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | M | 0.49 | 23,000 | 11,270 | 92,000 | |
Oct 04 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | M | 0.49 | 23,000 | 11,270 | 520,445 | 497.4 K to 520.4 K (+4.62 %) |
Aug 21 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | M | 0.85 | 23,000 | 19,550 | 69,000 | |
Aug 21 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | M | 0.85 | 23,000 | 19,550 | 497,445 | 474.4 K to 497.4 K (+4.85 %) |
Jul 27 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | J | 0.00 | 75,000 | 0 | 474,445 | 399.4 K to 474.4 K (+18.78 %) |
Jul 13 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | X | 1.50 | 110,000 | 165,000 | 0 | |
Jul 13 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | X | 1.50 | 110,000 | 165,000 | 399,445 | 289.4 K to 399.4 K (+38.00 %) |
Jul 11 2006 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | A | 1.50 | 110,000 | 165,000 | 110,000 | |
Nov 21 2005 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | A | 1.61 | 250,000 | 402,500 | 250,000 | |
Oct 14 2005 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | M | 0.54 | 13,445 | 7,260 | 0 | |
Oct 14 2005 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | M | 0.54 | 13,445 | 7,260 | 289,445 | 276 K to 289.4 K (+4.87 %) |
Nov 24 2004 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Sell | J | 0.00 | 900,000 | 0 | 426,000 | 1.3 M to 426 K (-67.87 %) |
Nov 24 2004 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Sell | J | 0.00 | 900,000 | 0 | 426,000 | 1.3 M to 426 K (-67.87 %) |
Oct 27 2004 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | P | 3.48 | 500 | 1,740 | 1,326,000 | 1.3 M to 1.3 M (+0.04 %) |
Oct 27 2004 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Buy | P | 3.55 | 2,000 | 7,100 | 1,325,500 | 1.3 M to 1.3 M (+0.15 %) |
Sep 15 2004 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | A | 6.73 | 250,000 | 1,682,500 | 250,000 | |
May 03 2004 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO | Option Exercise | A | 8.10 | 150,000 | 1,215,000 | 150,000 | |
Sep 23 2003 | ACEL.OB | Tamir Biotechnolog ... | SHOGEN KUSLIMA | CEO & Acting CFO | Option Exercise | A | 1.58 | 150,000 | 237,000 | 150,000 |
Page: 1